Association AP. Diagnostic and statistical manual of mental disorders, fifth edition (DSM-5). Washington, DC: Association AP; 2013.
Hedegaard H, Miniño A, Warner M. Drug overdose deaths in the United States, 1999–2018. 2020.
Administration. UDoHaHSSAaMHS. National survey on drug use and health. In: Administration. UDoHaHSSAaMHS, editor. 2018.
Spencer MR, Minino AM, Warner M. Drug overdose deaths in the United States, 2001–2021. NCHS Data Brief. 2022;457:1–8 (Epub 2023/01/05).
Addiction and substance misuse reports and publications. In: Services UDoHaH, editor. Rockville, MD; 2023.
Angarita GA, Emadi N, Hodges S, Morgan PT. Sleep abnormalities associated with alcohol, cannabis, cocaine, and opiate use: a comprehensive review. Addict Sci Clin Pract. 2016;11(1):9. https://doi.org/10.1186/s13722-016-0056-7.
Article PubMed PubMed Central Google Scholar
Brower KJ. Alcohol’s effects on sleep in alcoholics. Alcohol Res Health. 2001;25(2):110–25 (Epub 2001/10/05).
CAS PubMed PubMed Central Google Scholar
He S, Brooks AT, Kampman KM, Chakravorty S. The relationship between alcohol craving and insomnia symptoms in alcohol-dependent individuals. Alcohol Alcohol. 2019;54(3):287–94. https://doi.org/10.1093/alcalc/agz029. (Epub 2019/05/16).
Article CAS PubMed PubMed Central Google Scholar
Association AP. Diagnostic and statistical manual of mental disorders (5). Washington, DC: Association AP; 2003.
Ohayon MM. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev. 2002;6(2):97–111. https://doi.org/10.1053/smrv.2002.0186. (Epub 2003/01/18).
Morin CM, Bertisch SM, Pelayo R, Watson NF, Winkelman JW, Zee PC, et al. What should be the focus of treatment when insomnia disorder is comorbid with depression or anxiety disorder? J Clin Med. 2023;12(5):1975. https://doi.org/10.3390/jcm12051975. (Epub 2023/03/12).
Article PubMed PubMed Central Google Scholar
Perlis ML, Posner D, Riemann D, Bastien CH, Teel J, Thase M. Insomnia. Lancet. 2022;400(10357):1047–60. https://doi.org/10.1016/S0140-6736(22)00879-0. (Epub 2022/09/18).
Kessler RC, Ustun TB. The world mental health (WMH) survey initiative version of the World Health Organization (WHO) composite international diagnostic interview (CIDI). Int J Methods Psychiatr Res. 2004;13(2):93–121. https://doi.org/10.1002/mpr.168. (Epub 2004/08/07).
Association AP. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association; 2000.
Slee V. The international classification of diseases: ninth revision (ICD-9). Ann Intern Med. 1978;88(3):424–6.
Article CAS PubMed Google Scholar
Organization WH. The ICD-10 classification of mental and behavioral disorders: clinical description and diagnostic guidelines. Geneva: World Health Organization; 1992.
Medicine AAoS. The international classification of sleep disorders: diagnostic and coding manual. 2005. pp. 148–52.
Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193–213.
Article CAS PubMed Google Scholar
Gardner E. Addiction and brain reward and antireward pathways. In: Clark M, Treisman G, editors. Chronic pain and addiction. Basel: Karger; 2011. p. 22–60.
Fragale JE, James MH, Avila JA, Spaeth AM, Aurora RN, Langleben D, et al. The insomnia-addiction positive feedback loop: role of the orexin system. Front Neurol Neurosci. 2021;45:117–27. https://doi.org/10.1159/000514965. (Epub 2021/05/31).
Article PubMed PubMed Central Google Scholar
Watson CJ, Lydic R, Baghdoyan HA. Sleep and GABA levels in the oral part of rat pontine reticular formation are decreased by local and systemic administration of morphine. Neuroscience. 2007;144(1):375–86. https://doi.org/10.1016/j.neuroscience.2006.09.007. (Epub 2006/10/24).
Article CAS PubMed Google Scholar
Krause AJ, Simon EB, Mander BA, Greer SM, Saletin JM, Goldstein-Piekarski AN, et al. The sleep-deprived human brain. Nat Rev Neurosci. 2017;18(7):404–18. https://doi.org/10.1038/nrn.2017.55. (Epub 2017/05/19).
Article CAS PubMed PubMed Central Google Scholar
Wu M, Zhang X, Feng S, Freda SN, Kumari P, Dumrongprechachan V, et al. Dopamine pathways mediating affective state transitions after sleep loss. Neuron. 2024;112(1):141-54.e8. https://doi.org/10.1016/j.neuron.2023.10.002. (Epub 2023/11/06).
Article CAS PubMed Google Scholar
Harris GC, Wimmer M, Aston-Jones G. A role for lateral hypothalamic orexin neurons in reward seeking. Nature. 2005;437(7058):556–9. https://doi.org/10.1038/nature04071. (Epub 2005/08/16).
Article CAS PubMed Google Scholar
Harris GC, Wimmer M, Randall-Thompson JF, Aston-Jones G. Lateral hypothalamic orexin neurons are critically involved in learning to associate an environment with morphine reward. Behav Brain Res. 2007;183(1):43–51. https://doi.org/10.1016/j.bbr.2007.05.025. (Epub 2007/06/30).
Article CAS PubMed PubMed Central Google Scholar
Moorman DE, James MH, Kilroy EA, Aston-Jones G. Orexin/hypocretin neuron activation is correlated with alcohol seeking and preference in a topographically specific manner. Eur J Neurosci. 2016;43(5):710–20. https://doi.org/10.1111/ejn.13170. (Epub 2016/01/12).
Article PubMed PubMed Central Google Scholar
Gentile TA, Simmons SJ, Barker DJ, Shaw JK, Espana RA, Muschamp JW. Suvorexant, an orexin/hypocretin receptor antagonist, attenuates motivational and hedonic properties of cocaine. Addict Biol. 2018;23(1):247–55. https://doi.org/10.1111/adb.12507. (Epub 2017/04/19).
Article CAS PubMed Google Scholar
Illenberger JM, Flores-Ramirez FJ, Pascasio G, Matzeu A, Martin-Fardon R. Daily treatment with the dual orexin receptor antagonist DORA-12 during oxycodone abstinence decreases oxycodone conditioned reinstatement. Neuropharmacology. 2023;239: 109685. https://doi.org/10.1016/j.neuropharm.2023.109685. (Epub 2023/08/15).
Article CAS PubMed Google Scholar
Thannickal TC, John J, Shan L, Swaab DF, Wu MF, Ramanathan L, et al. Opiates increase the number of hypocretin-producing cells in human and mouse brain and reverse cataplexy in a mouse model of narcolepsy. Sci Transl Med. 2018. https://doi.org/10.1126/scitranslmed.aao4953. (Epub 2018/06/29).
Article PubMed PubMed Central Google Scholar
James MH, Stopper CM, Zimmer BA, Koll NE, Bowrey HE, Aston-Jones G. Increased number and activity of a lateral subpopulation of hypothalamic orexin/hypocretin neurons underlies the expression of an addicted state in rats. Biol Psychiatry. 2019;85(11):925–35. https://doi.org/10.1016/j.biopsych.2018.07.022. (Epub 2018/09/17).
Article CAS PubMed Google Scholar
Bunce SC, Harris JD, Bixler EO, Taylor M, Muelly E, Deneke E, et al. Possible evidence for re-regulation of HPA axis and brain reward systems over time in treatment in prescription opioid-dependent patients. J Addict Med. 2015;9(1):53–60. https://doi.org/10.1097/ADM.0000000000000087. (Epub 2014/12/04).
Article CAS PubMed Google Scholar
Huhn AS, Finan PH. Sleep disturbance as a therapeutic target to improve opioid use disorder treatment. Exp Clin Psychopharmacol. 2022;30(6):1024–35. https://doi.org/10.1037/pha0000477. (Epub 2021/06/11).
Article CAS PubMed Google Scholar
von der Goltz C, Koopmann A, Dinter C, Richter A, Grosshans M, Fink T, et al. Involvement of orexin in the regulation of stress, depression and reward in alcohol dependence. Horm Behav. 2011;60(5):644–50. https://doi.org/10.1016/j.yhbeh.2011.08.017. (Epub 2011/09/29).
Article CAS PubMed Google Scholar
Eban-Rothschild A, Borniger JC, Rothschild G, Giardino WJ, Morrow JG, de Lecea L. Arousal state-dependent alterations in VTA-GABAergic neuronal activity. eNeuro. 2020. https://doi.org/10.1523/ENEURO.0356-19.2020. (Epub 2020/02/15).
Comments (0)